Kubota Pharmaceutical Holdings CO Ltd (KBBTF) Financial Statements (2024 and earlier)

Company Profile

Business Address 4-20-3 EBISU
TOKYO, 150-0013
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 122,314112,010103,786
Cash and cash equivalents 8,9495,08818,778
Short-term investments 113,365106,92285,008
Receivables 2,0556,1405,285
Deferred tax assets   61
Other undisclosed current assets 2,9502,0512,582
Total current assets: 127,319120,201111,714
Noncurrent Assets
Property, plant and equipment 770920742
Long-term investments and receivables 18,97554,51584,033
Long-term investments 18,97554,51584,033
Other noncurrent assets 319314435
Deferred tax assets, net   42
Total noncurrent assets: 20,06455,74985,252
TOTAL ASSETS: 147,383175,950196,966
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 4,4605,8026,300
Employee-related liabilities 2,2952,4571,683
Accounts payable 439207441
Accrued liabilities 1,7263,1384,176
Deferred revenue and credits 1532,6106,256
Total current liabilities: 4,6138,41212,556
Noncurrent Liabilities
Liabilities, other than long-term debt 9531,10447
Deferred revenue and credits 9531,10447
Total noncurrent liabilities: 9531,10447
Total liabilities: 5,5669,51612,603
Equity
Equity, attributable to parent 141,817166,434184,363
Common stock 207,449191,696186,589
Additional paid in capital  6,2883,601
Accumulated other comprehensive loss (132)(575)(361)
Accumulated deficit (65,500)(30,975)(5,466)
Total equity: 141,817166,434184,363
TOTAL LIABILITIES AND EQUITY: 147,383175,950196,966

Income Statement (P&L) ($ in thousands)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
Revenues
(Revenue, Net)
 7,60624,06735,396
Gross profit: 7,60624,06735,396
Operating expenses (43,602)(50,623)(35,584)
Operating loss: (35,996)(26,556)(188)
Nonoperating income 1,4721,097541
Investment income, nonoperating 1,4081,117519
Interest and debt expense   (15)
Other undisclosed income from continuing operations before equity method investments, income taxes   15
Income (loss) from continuing operations before income taxes: (34,524)(25,459)353
Income tax expense (1)(50)(2,359)
Loss from continuing operations: (34,525)(25,509)(2,006)
Loss before gain (loss) on sale of properties: (34,525)(25,509)(2,006)
Net loss available to common stockholders, diluted: (34,525)(25,509)(2,006)

Comprehensive Income ($ in thousands)

3/31/2017
TTM
12/31/2016
12/31/2015
12/31/2014
Net loss: (34,525)(25,509)(2,006)
Comprehensive loss: (34,525)(25,509)(2,006)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 443(214)(354)
Comprehensive loss, net of tax, attributable to parent: (34,082)(25,723)(2,360)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: